liraglutide vs compounded semaglutide vs GLP-1 for Weight Loss Semaglutide vs Tirzepatide vs Liraglutide
Description
As a GLP-1 receptor agonist, semaglutide has been shown to improve blood sugar control in individuals with type 2 diabetes
The mean age of patients was 58 years, 5% were 75 years or older and 55% were male
The medication is safe and has a low cost
The combination achieved 20.4% mean body weight reduction from baseline to week 68 (22.7% under the trial product estimand that accounts for discontinuation)
in reality, the body is simply recalibrating, often doing meaningful internal work that isnt immediately visible
